Amazon Pharmacy is now offering same-day prescription medicine deliveries for customers in New York City and Los Angeles, with plans to expand to more than a dozen cities by the end of the year.

Since March 20, 10 more drugs are either in short supply or discontinued — and the healthcare supply chain industry is watching whether the collapse of a Baltimore bridge might cause disruptions. 

On March 28, U.S. News & World Report released its latest over-the-counter medicine and health products ranking.

Essentia Health, a 14-hospital system based in Duluth, Minn., launched a free tool March 26 to verbalize prescription labels. 

Patients, pharmacists and physicians are reporting a strained supply of Zepbound, Eli Lilly's new weight loss drug, as the drugmaker and the FDA say the medication is available, according to Bloomberg. 

FDA investigators said they found "objectionable conditions" during medication research at Columbia University Medical Center Kreitchman PET Center, according to a warning letter published March 26. 

During a yearslong dip of the FDA inspecting clinical research in hospitals and other care sites, the U.S. Government Accountability Office said the agency should bolster its retention and recruitment efforts. 

Five months before Colorado's Prescription Drug Affordability Board will vote on how much to cap the cost of Amgen's Enbrel, the drugmaker filed a lawsuit.

On March 26, the FDA approved a drug from Merck to treat adults with pulmonary arterial hypertension — a rare, progressive lung condition. 

About 30 pharmacists and pharmacy technicians at a Las Vegas CVS Omnicare filed to unionize March 25, making them the first in their industry to seek unionization. 

More than a year after the FDA yanked away authorization from Evusheld, a monoclonal antibody treatment for COVID-19, the agency granted emergency use authorization to a new COVID-19 preventive drug March 22. 

Wegovy and Ozempic maker Novo Nordisk has agreed to buy Cardior Pharmaceuticals for $1.11 billion. The acquisition is part of Novo Nordisk's larger strategy to build a portfolio of therapies in cardiovascular disease. 

A former CVS location is now occupied by a United Health Services pharmacy. 

On March 22, the FDA granted emergency use authorization to Pemgarda, a COVID-19 preventive medication, for patients 12 and older. 

The FDA has approved Duvyzat as the first nonsteroidal drug for patients with all genetic variants of Duchenne muscular dystrophy, the agency said March 21.

Researchers and pharmacists at West Virginia University are developing AI technology to streamline medication reconciliation in hospitals, or the standard of reviewing a patient's drug regimen before discharges. 

Mark Cuban Cost Plus Drug Co. expanded its pharmacy network March 20 with a deal with grocery chain Albertsons, growing its drug discount offering by another thousand-plus locations. 

The most expensive drug in the U.S. is now Lenmeldy, a $4.25 million gene therapy the FDA approved March 18 for children with a rare genetic disease. 

More than half of pharmaceuticals in the United States have a dependency on manufacturers not compliant to the Trade Agreements Act, which the Department of Defense defines as high- and very high-risk medications. 

In 2023, 63% of abortions were performed with abortion pills — an increase from 2020, when the figure was 53%, according to the Guttmacher Institute.